Skip to main content
Erschienen in: Endocrine 2/2012

01.10.2012 | Original Article

Clinical–pathological changes in differentiated thyroid cancer (DTC) over time (1997–2010): data from the University Hospital “Maggiore della Carità” in Novara

verfasst von: L. Pagano, M. Caputo, M. T. Samà, V. Garbaccio, M. Zavattaro, M. G. Mauri, F. Prodam, P. Marzullo, R. Boldorini, G. Valente, G. Aimaretti

Erschienen in: Endocrine | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Differentiated thyroid cancer (DTC) is an important clinical entity in our population (Novara, Piedmont, Italy) which is characterized by important environmental influences, as iodine deficiency (ID) and subsequent supplementation, thyroiditis and occupational exposure. To evaluate the features of DTC in our population 20 years after the iodine-prophylaxis pondering the effects of the introduction of the new guidelines for diagnosis and management of DTC after 2005. 322 patients [244 females, age: mean (±SD) 53.8 ± 15.8 years] treated for DTC in a tertiary care center between 1997 and 2010 were retrospectively evaluated. Medical history, demographics, and pathological features were considered. Patients were subdivided into two groups: A (n = 139, diagnosis 1997–2005) and B (n = 183, diagnosis 2006–2010). The population of group A showed a mild ID, while normal iodine status was recorded in group B. A significant increase in histological tumor-associated thyroiditis was found from group A to B (p = 0.021). Recurrent or persistent diseases were found to be correlated with lymph nodes metastases and/or a distant disease at diagnosis, stimulated thyroglobulin levels at the first follow-up and an additional radioiodine therapy. Twenty percent of our patients were females employed in textile industries. The tumor-related inflammation and the occupational exposure should be considered as important factors in the pathogenesis of DTC. Further studies are required in order to confirm our findings.
Literatur
1.
Zurück zum Zitat J.A. Sipos, E.L. Mazzaferri, Thyroid cancer epidemiology and prognostic variables. Clin. Oncol. 22, 395–404 (2010)CrossRef J.A. Sipos, E.L. Mazzaferri, Thyroid cancer epidemiology and prognostic variables. Clin. Oncol. 22, 395–404 (2010)CrossRef
2.
Zurück zum Zitat B.A. Kilfoy, T. Zheng, T.R. Holford et al., International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5), 525–531 (2009)PubMedCrossRef B.A. Kilfoy, T. Zheng, T.R. Holford et al., International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20(5), 525–531 (2009)PubMedCrossRef
5.
Zurück zum Zitat F. Pacini, M.G. Castagna, L. Brilli et al., Differentiated thyroid cancer: ESMOClinical reccomendations for diagnosis, treatment and follow up. Ann. Oncol. 19(2), 99–101 (2008)CrossRef F. Pacini, M.G. Castagna, L. Brilli et al., Differentiated thyroid cancer: ESMOClinical reccomendations for diagnosis, treatment and follow up. Ann. Oncol. 19(2), 99–101 (2008)CrossRef
6.
Zurück zum Zitat E.L. Mazzaferri, Managing low risk thyroid cancer. Endocr. Pract. 13(5), 499 (2007) E.L. Mazzaferri, Managing low risk thyroid cancer. Endocr. Pract. 13(5), 499 (2007)
7.
Zurück zum Zitat D.E. Thompson, K. Mabuchi, E. Ron et al., Cancer incidence in atomic bomb survivors, part II: solid tumors, 1958–1987. Radiat. Res. 137, S17–S67 (1994)PubMedCrossRef D.E. Thompson, K. Mabuchi, E. Ron et al., Cancer incidence in atomic bomb survivors, part II: solid tumors, 1958–1987. Radiat. Res. 137, S17–S67 (1994)PubMedCrossRef
8.
Zurück zum Zitat v. Gomez Segovia, H.J. Gallowitsch, E. Kresnik et al., Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984–2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid 14(4), 277–286 (2004)PubMedCrossRef v. Gomez Segovia, H.J. Gallowitsch, E. Kresnik et al., Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984–2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid 14(4), 277–286 (2004)PubMedCrossRef
9.
Zurück zum Zitat A. Belfiore, G.L. La Rosa, G. Padova et al., The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer 60, 3096–3102 (1987)PubMedCrossRef A. Belfiore, G.L. La Rosa, G. Padova et al., The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area. Cancer 60, 3096–3102 (1987)PubMedCrossRef
10.
Zurück zum Zitat R.A. Ott, A.R. McCall, H. Jarosz et al., The incidence of thyroid carcinoma in Hashimoto’s thyroiditis. Am. Surg. 53, 442–445 (1987)PubMed R.A. Ott, A.R. McCall, H. Jarosz et al., The incidence of thyroid carcinoma in Hashimoto’s thyroiditis. Am. Surg. 53, 442–445 (1987)PubMed
11.
Zurück zum Zitat G. Pellegriti, F. De Vathaire, C. Scollo et al., Papillary thyroid cancer incidence in the volcanic area of Sicily. J. Natl. Cancer Inst. 101, 1575–1583 (2009)PubMedCrossRef G. Pellegriti, F. De Vathaire, C. Scollo et al., Papillary thyroid cancer incidence in the volcanic area of Sicily. J. Natl. Cancer Inst. 101, 1575–1583 (2009)PubMedCrossRef
12.
Zurück zum Zitat E.Y. Wong, R. Ray, D.L. Gao et al., Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shangai, China. Int. Arch. Occup. Environ. Health 79, 251–258 (2006)PubMedCrossRef E.Y. Wong, R. Ray, D.L. Gao et al., Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shangai, China. Int. Arch. Occup. Environ. Health 79, 251–258 (2006)PubMedCrossRef
13.
Zurück zum Zitat WHO. Prevention and control of iodine deficiency disorders. Fifty-second world healthy assembly. Provisonal agenda item 13. Geneva; World Health Organization (1999) WHO. Prevention and control of iodine deficiency disorders. Fifty-second world healthy assembly. Provisonal agenda item 13. Geneva; World Health Organization (1999)
14.
Zurück zum Zitat F. Pacini, M. Schlumberger, H. Dralle et al., European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787–803 (2006)PubMedCrossRef F. Pacini, M. Schlumberger, H. Dralle et al., European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur. J. Endocrinol. 154, 787–803 (2006)PubMedCrossRef
15.
Zurück zum Zitat D.S. Cooper, G.M. Doherty, B.R. Haugen et al., Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16(2), 109–141 (2006)PubMedCrossRef D.S. Cooper, G.M. Doherty, B.R. Haugen et al., Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16(2), 109–141 (2006)PubMedCrossRef
16.
Zurück zum Zitat H. Gharib, E. Papini, R. Paschke, for the AACE/AME/ETA Task Force on Thyroid Nodules et al., American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association. Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr. Pract. 16(1), 1–43 (2010)PubMedCrossRef H. Gharib, E. Papini, R. Paschke, for the AACE/AME/ETA Task Force on Thyroid Nodules et al., American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association. Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr. Pract. 16(1), 1–43 (2010)PubMedCrossRef
17.
Zurück zum Zitat American Joint Committee on Cancer: Chapter 8: Thyroid in: AJCC cancer staging handbook. 6th edition. Spinger, New York, pp 89–98 (2002) American Joint Committee on Cancer: Chapter 8: Thyroid in: AJCC cancer staging handbook. 6th edition. Spinger, New York, pp 89–98 (2002)
18.
Zurück zum Zitat WHO, UNICEF, ICCIDD, Indicators for assessing iodine deficiency disorders and their control through salt iodination (World Health Organization, Geneva, 1992) WHO, UNICEF, ICCIDD, Indicators for assessing iodine deficiency disorders and their control through salt iodination (World Health Organization, Geneva, 1992)
19.
Zurück zum Zitat American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper, D.S., Doherty, G.M., Haugen, B.R. et al. Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11): 1167-1214 (2009) American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper, D.S., Doherty, G.M., Haugen, B.R. et al. Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11): 1167-1214 (2009)
21.
Zurück zum Zitat S. Lonati, A. Rapa, G. Di Dio et al., Iodine status in historically iodine deficiency area. Minerva Pediatr. 58(3), 255–256 (2006)PubMed S. Lonati, A. Rapa, G. Di Dio et al., Iodine status in historically iodine deficiency area. Minerva Pediatr. 58(3), 255–256 (2006)PubMed
22.
Zurück zum Zitat L. Enewold, K. Zhu, E. Ron et al., Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol. Biomarkers Prev. 18, 784–791 (2009)PubMedCrossRef L. Enewold, K. Zhu, E. Ron et al., Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol. Biomarkers Prev. 18, 784–791 (2009)PubMedCrossRef
23.
Zurück zum Zitat R. Elisei, E. Molinaro, L. Agate et al., Are the clinical and pathological features of differentiated thyroid carcinoma really changed over last 35 years? Study on 4187 patients from a single Italian Institution to answer to this question. J. Clin. Endocrinol. Metab. 95(4), 1516–1527 (2010)PubMedCrossRef R. Elisei, E. Molinaro, L. Agate et al., Are the clinical and pathological features of differentiated thyroid carcinoma really changed over last 35 years? Study on 4187 patients from a single Italian Institution to answer to this question. J. Clin. Endocrinol. Metab. 95(4), 1516–1527 (2010)PubMedCrossRef
24.
Zurück zum Zitat M. Rizzo, R.T. Rossi, O. Bonaffini et al., Increased annual frequency of Hashimoto’s thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. Ann. Endocrinol. (Paris) 71(6), 525–534 (2010)CrossRef M. Rizzo, R.T. Rossi, O. Bonaffini et al., Increased annual frequency of Hashimoto’s thyroiditis between years 1988 and 2007 at a cytological unit of Sicily. Ann. Endocrinol. (Paris) 71(6), 525–534 (2010)CrossRef
25.
Zurück zum Zitat S. Benvenga, F. Trimarchi, Changed presentation of Hashimoto’s thyroiditis in north-eastern Sicily and Calabria (southern Italy) based on a 31-year experience. Thyroid 18(4), 429–441 (2008)PubMedCrossRef S. Benvenga, F. Trimarchi, Changed presentation of Hashimoto’s thyroiditis in north-eastern Sicily and Calabria (southern Italy) based on a 31-year experience. Thyroid 18(4), 429–441 (2008)PubMedCrossRef
26.
Zurück zum Zitat G. Mazziotti, L.D. Premawardhana, A.B. Parkes et al., Evolution of thyroid autoimmunity during iodine prophylaxis—the Sri Lankan experience. Eur. J. Endocrinol. 149(2), 103–110 (2003)PubMedCrossRef G. Mazziotti, L.D. Premawardhana, A.B. Parkes et al., Evolution of thyroid autoimmunity during iodine prophylaxis—the Sri Lankan experience. Eur. J. Endocrinol. 149(2), 103–110 (2003)PubMedCrossRef
27.
Zurück zum Zitat P. Vitti, E. Martino, F. Aghini-Lombardi et al., Thyroid volume measurement by ultrasound in children as a tool for the assessment of mild iodine deficiency. J. Clin. Endocrinol. Metab. 79(2), 600–603 (1994)PubMedCrossRef P. Vitti, E. Martino, F. Aghini-Lombardi et al., Thyroid volume measurement by ultrasound in children as a tool for the assessment of mild iodine deficiency. J. Clin. Endocrinol. Metab. 79(2), 600–603 (1994)PubMedCrossRef
28.
Zurück zum Zitat F. Pacini, T. Vorontsova, E.P. Demidchik et al., Post Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and French. J. Clin. Endocrinol. Metab. 82(11), 3563–3569 (1997)PubMedCrossRef F. Pacini, T. Vorontsova, E.P. Demidchik et al., Post Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and French. J. Clin. Endocrinol. Metab. 82(11), 3563–3569 (1997)PubMedCrossRef
29.
Zurück zum Zitat M.J. Favus, A.B. Scneider, M.E. Stachura et al., Thyroid cancer occurring as late as consequence of head-and-neck irradiation. Evaluation of 1056 patients. N. Engl. J. Med. 294, 1019–1025 (1976)PubMedCrossRef M.J. Favus, A.B. Scneider, M.E. Stachura et al., Thyroid cancer occurring as late as consequence of head-and-neck irradiation. Evaluation of 1056 patients. N. Engl. J. Med. 294, 1019–1025 (1976)PubMedCrossRef
30.
Zurück zum Zitat L. García-Pascual, M.J. Barahona, M. Balsells et al., Complex thyroid nodules with nondiagnostic fine needle aspiration cytology: histopathologic outcomes and comparison of the cytologic variants (cystic vs. acellular). Endocrine. 39(1), 33–40 (2011)PubMedCrossRef L. García-Pascual, M.J. Barahona, M. Balsells et al., Complex thyroid nodules with nondiagnostic fine needle aspiration cytology: histopathologic outcomes and comparison of the cytologic variants (cystic vs. acellular). Endocrine. 39(1), 33–40 (2011)PubMedCrossRef
31.
Zurück zum Zitat L. García-Pascual, M. Balsells, M. Fabbi et al., Prognostic factors and follow-up of patients with differentiated thyroid carcinoma with false negative or nondiagnostic FNAC before surgery Comparison with a control group. Endocrine 40(3), 423–431 (2011)PubMedCrossRef L. García-Pascual, M. Balsells, M. Fabbi et al., Prognostic factors and follow-up of patients with differentiated thyroid carcinoma with false negative or nondiagnostic FNAC before surgery Comparison with a control group. Endocrine 40(3), 423–431 (2011)PubMedCrossRef
32.
Zurück zum Zitat D.T. Hughes, M.R. Haymart, B.S. Miller et al., The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21(3), 231–236 (2011)PubMedCrossRef D.T. Hughes, M.R. Haymart, B.S. Miller et al., The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21(3), 231–236 (2011)PubMedCrossRef
33.
Zurück zum Zitat J.M. Stulak, C.S. Grant, D.R. Farley et al., Value of preoperative ultrasonography in surgical management of initial and reoperative papillary thyroid cancer. Arch. Surg. 141, 489–494 (2006)PubMedCrossRef J.M. Stulak, C.S. Grant, D.R. Farley et al., Value of preoperative ultrasonography in surgical management of initial and reoperative papillary thyroid cancer. Arch. Surg. 141, 489–494 (2006)PubMedCrossRef
34.
Zurück zum Zitat T.Y. Ho, M.J. Liou, K.J. Lin et al., Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine 40(2), 297–302 (2011)PubMedCrossRef T.Y. Ho, M.J. Liou, K.J. Lin et al., Prevalence and significance of thyroid uptake detected by 18F-FDG PET. Endocrine 40(2), 297–302 (2011)PubMedCrossRef
35.
Zurück zum Zitat Y. Ito, T. Higashiyama, Y. Takamura et al., Risks factors for recurrence to the limph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J. Surg. 31, 2085–2091 (2007)PubMedCrossRef Y. Ito, T. Higashiyama, Y. Takamura et al., Risks factors for recurrence to the limph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J. Surg. 31, 2085–2091 (2007)PubMedCrossRef
36.
Zurück zum Zitat E.L. Mazzaferri, S.M. Jhiang, Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 97, 418–428 (1994)PubMedCrossRef E.L. Mazzaferri, S.M. Jhiang, Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 97, 418–428 (1994)PubMedCrossRef
37.
Zurück zum Zitat E. Sampson, J.D. Brierley, L.W. Le et al., Clinical management and outcome of papillary and follicular (differentiated thyroid cancer) presenting with distant metastasis at diagnosis. Cancer 110, 1451–1456 (2007)PubMedCrossRef E. Sampson, J.D. Brierley, L.W. Le et al., Clinical management and outcome of papillary and follicular (differentiated thyroid cancer) presenting with distant metastasis at diagnosis. Cancer 110, 1451–1456 (2007)PubMedCrossRef
38.
Zurück zum Zitat M.G. Castagna, L. Brilli, T. Pilli et al., Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. J. Clin. Endocrinol. Metab. 93(1), 76–81 (2008)PubMedCrossRef M.G. Castagna, L. Brilli, T. Pilli et al., Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels. J. Clin. Endocrinol. Metab. 93(1), 76–81 (2008)PubMedCrossRef
39.
Zurück zum Zitat R.M. Tuttle, T. Hernan, J. Shas et al., Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by The New Thyroid Association Staging System. Thyroid 20(12), 1341–1349 (2010)PubMedCrossRef R.M. Tuttle, T. Hernan, J. Shas et al., Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by The New Thyroid Association Staging System. Thyroid 20(12), 1341–1349 (2010)PubMedCrossRef
Metadaten
Titel
Clinical–pathological changes in differentiated thyroid cancer (DTC) over time (1997–2010): data from the University Hospital “Maggiore della Carità” in Novara
verfasst von
L. Pagano
M. Caputo
M. T. Samà
V. Garbaccio
M. Zavattaro
M. G. Mauri
F. Prodam
P. Marzullo
R. Boldorini
G. Valente
G. Aimaretti
Publikationsdatum
01.10.2012
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2012
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9612-4

Weitere Artikel der Ausgabe 2/2012

Endocrine 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.